BLU

BELLUS Health Inc.

Price

return (12m)

0.00%

p/e

-21.50

p/bv

5.06

DIVIDEND YIELD

0.00%

BLU price

BELLUS Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BLU

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BLU

Valuation

P/E

-21.50

Sector -3.98

Industry -3.98

P/BV

5.06

Sector 2.00

Industry 2.00

P/Revenue (PSR)

124,387.50

Sector -4.41

Industry -4.41

EV/EBITDA

Sector -245.01

Industry -245.01

EV/EBIT

Sector -666.51

Industry -666.51

P/EBITDA

-21.10

Sector -4.07

Industry -4.07

P/EBIT

-21.02

Sector -4.24

Industry -4.24

P/Total Assets

4.92

Sector 1.40

Industry 1.40

P/Net Current Assets

Sector -11.65

Industry -11.65

P/Working Capital

Sector -10.95

Industry -10.95

EPS

-0.69

Sector -2.20

Industry -2.20

BVPS

2.91

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

46.67%

Sector 36.05%

Industry 36.05%

EBITDA Margin

-924,133.33%

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

-927,600.00%

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

-100.00%

Sector -38.74%

Industry -38.74%

Net Profit Margins

-100.00%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-23.53%

Sector -66.41%

Industry -66.41%

ROA

-22.87%

Sector -66.55%

Industry -66.55%

ROIC

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -14.63

Industry -14.63

Net Debt / EBIT

Sector -7.24

Industry -7.24

Net Debt / Equity

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

Sector -0.02

Industry -0.02

Equity/Assets

0.97

Sector 0.42

Industry 0.42

Liabilities/Assets

0.97

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-1.28%

Sector -

Industry -

5Y Earnings CAGR

4.03%

Sector -

Industry -

Fundamentals BLU

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
BLU	-21.50	5.06	-23.53%	0.00%	$1.87 B	-100.00%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BLU Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/11/2011	03/22/2011	0.01080000
Dividends	12/29/2010	01/14/2011	0.02160000
Dividends	04/07/2009	04/24/2009	0.06480000
Dividends	12/25/2008	01/09/2009	0.06480000
Dividends	10/08/2008	10/24/2008	0.09720000
Dividends	07/09/2008	07/25/2008	0.11880000
Dividends	04/09/2008	04/25/2008	0.12960000
Dividends	12/27/2007	01/11/2008	0.14040000
Dividends	10/10/2007	10/26/2007	0.09720000
Dividends	07/11/2007	07/27/2007	0.03240000
Dividends	04/11/2007	04/27/2007	0.14040000
Dividends	12/27/2006	01/12/2007	0.15120000
Dividends	10/11/2006	10/27/2006	0.14040000
Dividends	07/12/2006	07/28/2006	0.14040000
Dividends	04/11/2006	04/28/2006	0.15120000
Dividends	12/28/2005	01/13/2006	0.11880000
Dividends	10/12/2005	10/28/2005	0.14040000
Dividends	07/13/2005	07/29/2005	0.14040000
Dividends	04/13/2005	04/29/2005	0.14040000
Dividends	12/29/2004	01/14/2005	0.15120000
Dividends	10/13/2004	10/29/2004	0.12960000
Dividends	07/14/2004	07/30/2004	0.14040000
Dividends	04/14/2004	04/30/2004	0.14040000
Dividends	12/29/2003	01/16/2004	0.14040000
Dividends	10/08/2003	10/24/2003	0.12960000

ABOUT BELLUS Health

BELLUS Health Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2000

Time since IPO - 26 years

32

Employees

BELLUS Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.87 billion, with shareholders equity totaling $368.90 million.

The company employs approximately 32 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BELLUS Health Inc. reported $15.00 Thousand in revenue, generating net income of $-86.79 million.

Key financial metrics include a P/E ratio of -21.50, a price-to-book (P/B) ratio of 5.06, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BLU.

Market cap

$1.87 billion

Net worth

$368.90 million

$368,904,000.00

Assets

$379.54 million

$379,543,000.00

Total Shares Outstanding

126.58 million

126,581,000

Average Daily Trading Volume

$6.60 million

$6,597,661.10

Sector

Health Care

Industry

Biotechnology

BLU

BLU revenue and profits

Financial Results BLU

DRAG THE FRAME TO SEE MORE DATA

BLU cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$877.23 25,29% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$239.23 54,37% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$257.59 55,58% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$246.20 30,54% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$128.33 67,99% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$161.50 10,88% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$44.53 --4,26% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$877.23 25,29% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$239.23 54,37% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$257.59 55,58% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$246.20 30,54% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$128.33 67,99% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$161.50 10,88% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$44.53 --4,26% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of BELLUS Health (BLU) today?

A cotação de BELLUS Health (BLU) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de BELLUS Health (BLU) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BELLUS Health (BLU) e dados de ações do Ibovespa e mercados internacionais.

Quando BELLUS Health (BLU) paga dividendos?

BELLUS Health (BLU) não distribuiu dividendos no último ano.

Is BELLUS Health (BLU) a good investment?

Atualmente, BELLUS Health (BLU) está cotada a US$ 0.00, com um P/L de -21.50, representando um desvio de -1,759% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BELLUS Health (BLU) stock?

Investir em ações de BELLUS Health (BLU) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of BELLUS Health (BLU) yield today?

A rentabilidade de BELLUS Health (BLU) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de BELLUS Health (BLU) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BLU

BELLUS Health Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BLU

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT BELLUS Health

BELLUS Health Inc.

United States

14 years

2000

32

PROFIT X PRICE BLU

Financial Results BLU

BLU cash flow

Asset, Revenue and Profit Growth - BLU

BLU balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions